Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia.
Ibrahim Aldoss, Dongyun Yang, Ahmed Aribi, Haris Ali, Karamjeet Sandhu, Monzr M Al Malki, Matthew Mei, Amandeep Salhotra, Samer Khaled, Ryotaro Nakamura, David Snyder, Margaret O'Donnell, Anthony S Stein, Stephen J Forman, Guido Marcucci, Vinod Pullarkat
Author Information
- Ibrahim Aldoss: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Dongyun Yang: Department of Information Sciences, Division of Biostatistics, City of Hope, Duarte, CA, USA.
- Ahmed Aribi: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Haris Ali: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Karamjeet Sandhu: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Monzr M Al Malki: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Matthew Mei: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Amandeep Salhotra: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Samer Khaled: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Ryotaro Nakamura: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- David Snyder: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Margaret O'Donnell: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Anthony S Stein: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Stephen J Forman: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Guido Marcucci: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
- Vinod Pullarkat: Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA vpullarkat@coh.org.
No abstract text available.
- Cell Stem Cell. 2013 Mar 7;12(3):329-41
[PMID: 23333149]
- N Engl J Med. 2016 Jan 28;374(4):311-22
[PMID: 26639348]
- Leukemia. 2014 Aug;28(8):1657-65
[PMID: 24451410]
- Leuk Res. 2015 Feb;39(2):124-30
[PMID: 25524177]
- Blood. 2017 Nov 30;130(22):2401-2409
[PMID: 29018077]
- Blood. 2015 Jul 16;126(3):291-9
[PMID: 25987659]
- J Clin Oncol. 2003 Dec 15;21(24):4642-9
[PMID: 14673054]
- Blood. 2019 Jan 3;133(1):7-17
[PMID: 30361262]
- Blood. 2017 Jan 26;129(4):424-447
[PMID: 27895058]
- J Clin Oncol. 2010 Feb 1;28(4):562-9
[PMID: 20026804]
- Cancer Discov. 2016 Oct;6(10):1106-1117
[PMID: 27520294]
Antineoplastic Combined Chemotherapy Protocols
Bridged Bicyclo Compounds, Heterocyclic
Decitabine
Drug Resistance, Neoplasm
Humans
Leukemia, Myeloid, Acute
Recurrence
Retreatment
Sulfonamides
Survival Analysis
Treatment Outcome
Bridged Bicyclo Compounds, Heterocyclic
Sulfonamides
Decitabine
venetoclax
